Nine years' experience with tolbutamide in the treatment of diabetes.
D000380:Agranulocytosis / Q000139:chemically induced; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011693:Purpura / Q000139:chemically induced; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced; D014044:Tolbutamide / Q000009:adverse effects / Q000627:therapeutic use*
D014044:Tolbutamide